To further investigate the function of ATRX in the DNA damage repair signaling pathway, Garbarino et al. created isogenic wild-type and ATRX knockout glioma cell lines using CRISPR-based gene targeting. The gene discussed is ATRX; the disease is central nervous system cancer.